Jia-Ming Chang

发表

Synthesis and structure-activity relationship of 3-O-acylated (-)-epigallocatechins as 5α-reductase inhibitors.

Young-Sun Lin, R. Hiipakka, Chu-Bin Liao, 2010, European journal of medicinal chemistry.

Discovery of T-1101 tosylate as a first-in-class clinical candidate for Hec1/Nek2 inhibition in cancer therapy.

Mengyu Chen, Yu-Hsiang Lin, Kuan-Pin Huang, 2020, European journal of medicinal chemistry.

Discovery of 4-aryl-N-arylcarbonyl-2-aminothiazoles as Hec1/Nek2 inhibitors. Part I: optimization of in vitro potencies and pharmacokinetic properties.

Yu-Hsiang Lin, Shih‐Hsien Chuang, Jia-Ming Chang, 2014, Journal of medicinal chemistry.

Stem Cell Therapy: Are we Ready to use it?

Jia-Ming Chang, P. Tsai, Yichu Lin, 2014 .

Inhibition of Hec1 as a novel approach for treatment of primary liver cancer

R. Gish, K. Kao, G. M. Lau, 2014, Cancer Chemotherapy and Pharmacology.

Activity of a Novel Hec1-Targeted Anticancer Compound against Breast Cancer Cell Lines In Vitro and In Vivo

K. Kao, G. M. Lau, Shih‐Hsien Chuang, 2014, Molecular Cancer Therapeutics.

The Potential Therapeutic Cells in Vascular Dementia: IL-1beta Enhanced Endothelial Progenitor-like Cells

Jia-Ming Chang, P. Tsai, Chun-Ming Cheng, 2018 .

Discovery of pyrrole-indoline-2-ones as Aurora kinase inhibitors with a different inhibition profile.

Weilin Chi, Chu-Bin Liao, Yu-Hsiang Lin, 2010, Journal of medicinal chemistry.

Alkyl Substituted Hydantoin-Based N-Halamine: Preparation, Characterization, and Structure–Antibacterial Efficacy Relationship

Xiaoniu Yang, Zhaobin Chen, Jia-Ming Chang, 2016 .

Targeting cancer stemness mediated by BMI1 and MCL1 for non‐small cell lung cancer treatment

M. Hsiao, Cheng-Wen Wu, Tsung-Hsien Lin, 2022, Journal of cellular and molecular medicine.

Characterization of the biological activity of a potent small molecule Hec1 inhibitor TAI-1

K. Kao, Shih‐Hsien Chuang, Jia-Ming Chang, 2014, Journal of Experimental & Clinical Cancer Research.